Why are squamous cancers so aggressive in recessive dystrophic epidermolysis bullosa? Can we find new therapeutic approaches?

Br J Dermatol. 2023 Dec 20;190(1):7-8. doi: 10.1093/bjd/ljad392.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Epidermolysis Bullosa Dystrophica* / genetics
  • Epidermolysis Bullosa Dystrophica* / pathology
  • Epidermolysis Bullosa Dystrophica* / therapy
  • Humans
  • MicroRNAs*
  • Skin / pathology

Substances

  • MicroRNAs